Partnership Prospectus

Congress Schedule

Correct at time of publishing and subject to change, this includes program topics and their location.

Day 1 - Thursday 4 August
Virtual sessions only
0900-1030
APGC abstract session 1
Chairperson: Visanee Tantisevi and Vijaya Lingham
Prospective Multicentre Trial of iStent infinite Trabecular Micro-Bypass in Glaucoma Uncontrolled by Prior Surgical or Medical Therapy
Robert Ang

Complications and Post-operative Interventions after XEN45 Gel Stent Implantation in the Treatment of Open Angle Glaucoma – A Meta Analysis
Bjorn Betzler

Combined Ab-interno Canaloplasty (ABiC) in open and angle closure glaucoma: 12 month outcomes
Jason Cheng

Comparison of extended depth of focus and monofocal intraocular lenses in glaucomatous eyes
Nathan Kerr

Comparative study of 2-year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery
Colin Clement

Comparison of Short-Term Clinical Outcome between Ahmed Valve Implant versus Non-valved Paul implant in Malaysian Glaucoma patients
Sze Lian Loh

Intraocular Pressure Control After Trabeculectomy with Intraoperative Subtenon Injection of Mitomycin – C
Pir Salim Mahar

Dual Blade Goniotomy in Addition to Usual Fenestrating Slits to Enhance Early Intraocular Pressure Lowering in Non-Valved Aqueous Shunt Surgery for Primary Open Angle Glaucoma
Mary Qiu

Comparison of choroidal thickness after topical prostaglandin therapy in primary open angle glaucoma patients- a case series
Gajashree S

Online Perimetry: Validation, comparison with standard automated perimetry and patient appraisal
Simon Skalicky

Incidence of Hypotony Post Glaucoma Drainage Device Implantation: Paul vs Baerveldt
Melissa Pei Yin Wang

Q&A
1030-1100
Break
1100-1230
American Glaucoma Society (AGS) symposium: Best of AGS
Chairpersons: Pradeep Ramulu and Pratap Challa
The LiGHT Trial: 6-Year Follow-Up Results
Evgenia Konstantakopoulou

Rate of Visual Field Progression among Participants who developed POAG in Phase 1 or 2 in the Ocular Hypertension Treatment (OHTS) Study
James Brandt

Visual Field Outcomes from the Randomized, Multicenter, HORIZON trial
Giovanni Montesano

Effectiveness of Micro-invasive Glaucoma Surgery in the United States: IRIS Registry Longitudinal Analysis 2013-2018
Shuang-An Yang

Genetic Factors Associated with Primary Open Angle Glaucoma (POAG) in the Ocular Hypertension Treatment Study (OHTS)
John Fingert

Prospective, Randomized, Multicenter, Open-label, 12-Month Evaluation of the Effectiveness and Safety of the Gel Stent vs Trabeculectomy: the Gold Standard Pathway Study (GPS)
Arsham Sheybani

Q&A
1230-1300
Break
1300-1430
World Glaucoma Association (WGA) symposium: Bleb and non-bleb based surgeries: pearls from international experts
Chairpersons: Kaweh Mansouri and Tanuj Dada
Micropulse TLT: Clinical pearls for the best results
Jose Martinez de la Casa

Canaloplasty or Goniotomy: which is best?
Inder Paul Singh

Stenting: how to make them work for the patient
Kyung Rim Sung

XEN: Inside Out vs.Outside In?
Kaweh Mansouri

TRABS: Best practices for successful outcomes
Paul Healey

Tubes: optimising your outcomes
Da Wen Lu

Q&A
1430-1500
Break
1500-1630
APGC Film Festival
Chairpersons: Joseph A. Tumbocon and Do Tan
How to do Guided Implantation of Ahmed Glaucoma Valve and Its Usefulness
Chang Kyu Lee

Does Size Matter?
Yong Zheng Wai

Releasable Suture in Trabeculectomy - A Boon to Glaucoma
Rishika Lakshminarayana

Surgical techniques for management of hypotonic maculopathy
Nidhi Chauhan

XEN Resuscitation: Management of complications
Suho Lim

Novel Use of the Intra-Operative Optical Coherence Tomography in Trabecular Bypass Minimally Invasive Glaucoma Surgery
Bryan Ang

A start to Trabectome Surgery: Must know tips and tricks!
Sahebaan Sethi

The Do-It-Yourself, Novel, Safe & Cost-Effective Diagnostic Cubicle for Glaucoma Practice in The COVID-19 Era
Prasanna Venkatesh Ramesh

Tailoring the Tube – Managing complications of Glaucoma Drainage Devices.
Amit Pandey

Affordable MIGS- Training & Surgery
Smita Narayanan

Q&A
1630-1700
Break
1700-1830
Normal pressure glaucoma
Chairperson: Mimiwati Zahari and David Wen Wei Woo
OCTA in NTG
Lan-Hsin Chuang

Cognitive impairment in NTG
Puspha Raman

Risk factors associated with progression in normal-tension glaucoma: systemic blood pressure
Hyoung Won Bae

Risk factor of progression in NTG with lower IOP controlled under 13mmHg
Rei Sakata

Special attention to disc hemorrhage in NTG
Kazuhisa Sugiyama

NTG- and metabolic syndrome
Virna Dwi Oktariana Asrory

Obesity, nutrient supply and glaucoma
Joon Kim

Q&A
1830-1930
Industry symposium: Introducing Hydrus® Microstent Into your Clinical Practice

Moderator: Chelvin Sng

Introduction and Opening Remarks
Moderator: Chelvin Sng

Hydrus® Outcomes in the 5 year HORIZON Trial
Graham Lee

Hydrus® Microstent Surgical Implantation Steps
Shamira Perera

Integrating into Practice with Hydrus®
Nathan Kerr

Moderated Q&A
Dr Chelvin Sng & Panel


Brought to you by

Day 2 - Friday 5 August
Virtual sessions only
0900-1030
MSJOC oral presentations
Chairpersons: Mae-Lynn Catherine Bastion and Teh Wee Min
In vitro and in vivo Biodegradation of PHA polymer: Regenerative Strategy for Corneal Application
Bakiah Shaharuddin

Dry Eye Management with Diquafosol 3% Eyedrops Before and After Cataract Surgery
Mun Wai Lee

Machine learning for predicting childhood myopia progression
Yong Li

Conditioned Media from Mesenchymal Stem Cells Upregulates Corneal Epithelial Genes Expression on PHA
Bakiah Shaharuddin

Retinal neural dysfunction in diabetes revealed with handheld chromatic pupillometry
Tan Tien-En

Intra-arterial Chemotherapy for Retinoblastoma: 7-years outcomes in Malaysia
Yong Zheng Wai

Umbilical cord plasma therapy for recalcitrant dry eye disease in a local Singaporean context
Joy Wong

Q&A
1030-1100
Break
1100-1230
International Society of Glaucoma Surgery (ISGS) symposium: reducing risk in glaucoma surgery
Tubes in older patients as primary treatment
Andy Crichton

Reducing variation in outcome of trabeculectomy
Surinder Pandav

Reducing needling rates in XEN implants
Michael Coote

Reducing rick in vulnerable and isolated patient groups
Tarek Shaaraway

Auditing risk management in surgery
Kerr Brogan

Managing the stent in GDD - tips and pearls
Keith Barton

Q&A
1230-1300
Break
1300-1430
APGC abstract session 2
Chairperson: Ningli Wang and Nazrul Islam
Effect of Trans-resveratrol on NMDA Induced Retinal Injury: Involvement of AA1R
Afiqq Aiman

Incidence and factors associated with brimonidine allergy
Sunee Chansangpetch

Caregiver burden in Childhood Glaucoma
Nidhi Chauhan

Combined phaco-emulsification and trabecular micro-bypass stent (iStent inject) for management of cataract and glaucoma: prospective longitudinal outcomes from the Fight Glaucoma Blindness Registry
Colin Clement

Reduced intradisc vessel density is associated with optic disc hemorrhage in eyes with primary open-angle glaucoma
Ko Eun Kim

PreserFlo™ Microshunt: Safety and Efficacy Outcomes in Uveitic Glaucoma
Jonathan Kirk

Assessment of the Anterior Chamber Angle and Central Biometric Parameters with Hyperparallel Optical Coherence Tomography
Natalia Porporato

The efficacy and safety of prostaglandin analogues/ timolol fixed combinations in glaucoma and ocular hypertension: a systematic review and meta-analysis
Parin Trabwongwitaya

Iridolenticular Contact Area, Pupil Block and Primary Angle Closure
Tin A Tun

Low Optic Disc Perfusion Evaluated with Swept Source Optical Coherence Tomography Angiography is Associated with Visual Field Progression in Open Angle Glaucoma
Jooyoung Yoon

Q&A
1430-1500
Break
1500-1645
Trabeculectomy and GDD: How to improve outcomes
Chairpersons: Ikke Sumantri and Norshamsiah Md Din

Improving surgical technique of trabeculectomy
Nazrul Islam

Filtration surgery with stent
Prin Rojanapongpun

Rescuing of failing trab
Michael Coote

Improving outcome of GDD
Paul Chew

Managing cataract along with tubes surgery
Ishtiaque Answar

Fixing common complications of GDD
Victor Koh

Placement of GDD tube: anterior chamber or sulcus?
Ch'ng Tun Wang

Q&A
1645-1700
Break
1700-1830
Video symposium on challenging situations in glaucoma surgery
Chairpersons: Chan Yun Kim, Da Wen Lu and Gan Eng Hui
The art of deep sclerectomy
Andre Mermoud

Filtration surgery at the inferior limbus - when and how
Leon Au

iStent misadventures & how to manage
Bryan Ang

Difficult xen implantation: stay zen
Kaweh Mansouri

How to restore a failing filter
Vital Costa

Ab interno repair of a cyclodialysis created while doing GSL
Shamira Perera

Difficult situations after tubes
SS Pandav

Surgical management of nanophthalmos with glaucoma
Sirisha Senthil

How to manage hypotony maculopathy
Paul Palmberg

Challenges in congenital glaucoma
Alana Grajewski

Q&A
1730-2000
Hybrid wetlab featuring the Hydrus® Microstent

Facilitators: Bryan Ang, Shamira Perera, Nathan Kerr
delivery mode: in person only

In-Person WetLab Session
Hydrus® instructors
delivery mode: in person only

WetLab Virtual Broadcast
delivery mode: in person and virtual broadcasting

Didactic Session & Hands-On WetLab
Nathan Kerr, Shamira Perera, Bryan Ang
delivery mode: in person and virtual broadcasting

Close


Brought to you by

Day 3 - Saturday 6 August
Hybrid sessions
0815-0830
Opening of APGC 2022

Opening comments from APGC 2022 Congress Chair
SK Fang

Opening comments from APGS President
Ki Ho Park

Opening comments from MSJOC Congress Chair
Hon Seng Wong

Opening comments from MSO President
Mano Shunmugan

Opening comments from SSO President
Lee Shu Yen
0830-1000
PLENARY SESSION
Hot topics in glaucoma
Chairpersons: Paul Healey and Jemaima Che Hamzah
New IOP lowering agent
Reza Razeghinejad

Micropulse trans-scleral cyclophotocoagulation: when? Who? Optimal setting?
Shan Lin

Multifocal IOL in glaucoma patients / EDOF IOLs
Catherine Liu

Visual rehabilitation for patient with glaucoma: where are we now?
Liza Sharmini Ahmad Tajudin

Aqueous outflow regulation - 21st century concepts
Chen Xin

Role of intraocular MIGS without conjunctival incision: when? who? tips for surgical success
Kaweh Mansouri

Optimising microtube implantation
Peng Khaw

Diagnostic accuracy of total macular thickness in glaucoma
Mimiwati Zahari

Q&A
1000-1030
Break
1030-1200
Paediatric Ophthalmology
Chairpersons: Jamalia Rahmat, Lai Yi En and Tsiang Ung
Myopia progression and online learning
Safinaz Mohd Khialdin

Acquired esotropia and digital eye strain
Shatriah Ismail

Pediatric craniosynostosis - a difficult year due to pandemic restrictions
Choo May May

Intraarterial chemotherapy in retinoblastoma
Norhafizah Hamzah

Refractive surgery in children
Azura Ramlee

Gene therapy in paediatric ophthalmology
Chan Hwei Wuen

Intermittent exotropia - early or late surgery
Norazah Abdul Rahman

Great mimics in paediatric ophthalmology
Fazilawati A. Qamarrudin

Panel discussion
1200-1330
Lunch
1215-1330
Expert Panel:
The Three Wishes of Glaucoma Management -
Early diagnosis, Effective treatment & Enhanced adherence


Chair:Seng Kheong Fang
Expert panel: Makoto Aihara, Ki Ho Park


Brought to you by

1330-1500
PLENARY SESSION
Current concepts in primary angle closure disease
Chairperson: Mohd Aziz Husni
Effect of myopia and cataract surgery on burden of angle closure disease in Asia
Mingguang He

Genetics of angle closure disease - what we have learnt?
Tin Aung

Evidence based management options for PACS, PAC and PACG
Lingam Vijaya

Diagnostic tools for angle closure disease - Gonioscopy or anterior segment OCT?
Kyung Rim Sung

Management options for acute primary angle closure (APAC)
Clement Tham

Internal drainage surgery - goniosynechialysis, MIGS and other newer options
Xiulan Zhang

Aqueous misdirection and other secondary angle closures
Tetsuya Yamamoto

Utility of AI in diagnosing PACD
Benjamin Xu

Q&A
1500-1530
Break
1530-1700
Cornea
Chairpersons: K John Mathen and Marcus Ang
Clinical pearls in managing infectious keratitis
Chandramalar Santhirathelagan

Allergic eye disease management
Wan Haslina

Descematopexy in descement's membrane detachment after cataract surgery
Siti Nor Roha

Management of OSSN
Che Mahiran

Role of contact lens in ocular surface disorder
On Heong Liew

DMEK - Learning curve and pearls to overcome
Anshu Arundhati

Panel discussion
1530-1700
APGS Biennial GM Meeting
1700-1800
DuoTrav® and Simbrinza® for IOP Lowering

Chair: Mimiwati Binti Zahari

The Recent Advances in Glaucoma Management
Tin Aung


Brought to you by


1800-1900
Networking drinks
1900-2030
European Glaucoma Society (EGS) symposium: Highlights from the EGS congress in Athens 2022
Chairperson: Luis Pinto and Ananth Viswanathan
EGS guidelines on surgical innovation
Luis Abegao Pinto

Will genotyping change our everyday practice in the future
Ananth Viswanathan

Choosing wisely - avoid fiddling with timing of surgery while Rome burns
Stylianos Kandarakis

Can glaucoma be reversed with neuroregeneration?
Keith Martin

The EGS patient project
Stelios Georgoulas

Q&A
Day 4 - Sunday 7 August
Hybrid sessions
0830-1000
Retina
Chairpersons: Hon Seng Wong and Daniel Ting
Relevant imaging features in managing wet & dry AMD
Embong Zunaina

Non-exudative AMD
Daniel Ting

Fluid or no fluid in managing AMD
Tara Mary George

Persistent fluid in neovascular AMD: optimising treatment regime
Gavin Tan

Learnings from local wet AMD patients: Pagenax related IOI
Shelina Oli Mohamad

Better efficacy and longer durability: new agents in management of wet AMD
Wong Jun Shyan

PCV: Is there still a role for PDT?
Norfariza Ngah

Challenging cases in AMD
Barkeh Hanim

Panel discussion
0830-1000
APGS President’s Summit
1000-1030
Break
1030-1200
Minimally invasive glaucoma surgery
Chairpersons: Colin Clement and Ng Hong Kee
Troubleshooting subconjunctival MIGS
Keith Barton

Aqueous angiography guided MIGS
Tanuj Dada

Japanese clinical study of Preserflo Microshunt and its potential
Makoto Aihara

Surgical predictor of Xen Gel Stent
Seungsoo Rho

Advances in ab interno canaloplasty
Nathan Kerr

Suprachoroidal drainage
Tarek Shaarawy

Microhook ab-interno trabeculotomy
Masaki Tanito

Q&A
1200-1330
Lunch
1200-1300
MSO-SSO YO session

Introduction
Chan Jan Bond

Update from MSO YO
Sudhashini Chandrasekaran

Update from SSO YO
Wong Chee Wai

MSO-SSO YO potential collaboration: discussion session

APAO YO rising stars program
Marcus Ang

YO to YO: residency, training and fellowship
Pushpa Raman and Daniel Ting
1330-1500
Cataract/refractive surgery
Chairpersons: Lee Mun Wai and Zainah Alsagoff
Introduction and definition
Miswan Muiz Mayhudin

Laser vision correction
Miswan Muiz Mayhudin

Implantable contact lens
Mohamad Rosman

Lens options for cataract and clear lens exchange
Khairidzan Mohd Kamal

Ocular biometry for high myopia
Fam Han Bor

Pearls for high myope cataract surgery
Lee Mun Wai

Q&A
1500-1530
Break
1530-1700
PLENARY SESSION
APGS Presidential symposium: Imaging in glaucoma with OCT and AI
Chairpersons: Tin Aung, Ki Ho Park and Liza Sharmini
Detection of early glaucoma using OCT
Joel Schuman

AI in glaucoma care
Felipe Medeiros

OCT in myopic glaucoma
Ki Ho Park

Estimation of the central 10-degree visual field using en-face images obtained by optical coherence tomography
Takeo Fukuchi

AI in glaucoma diagnosis and prediction
Xiulan Zhang

Describing the structure and biomechanical phenotype of glaucoma using AI
Michael Girard

Glaucoma diagnostics in the era of high-resolution imaging and AI: a new horizon
Jin Wook Jeoung

Q&A
1700-1830
Awards symposium and closing ceremony
Chairperson: Jelinar Mohamed Noor and SK Fang
APGC and MSJOC awards
- APGC 2022 best free paper oral award
- APGC Film Festival award
- MSJOC best paper oral award
- MSJOC best paper poster award


Young Investigator Award presentation
Chelvin Sng

Asia Pacific Award presentation: Optic disc hemorrhage and its clinical significance
Tetsuya Yamamoto

International Award presentation
Neeru Gupta

Keshmahinder Singh Oration: Innovations and advances in translational research
Peng Khaw

MGS Distinguished Service Award
Ropilah Abdul Rahman

MSO Keynote Lecture: Diabetic vitrectomy - is there still a role in the age of anti-VEGF?
Lee Shu Yen

For all sponsor and exhibition enquiries contact:

Dr Seng Kheong Fang
APGS President Elect & Congress Chair APGC 2022

Or

Thomas Howden

Industry Liaison
Asia-Pacific Glaucoma Congress 2022
c/o MCI Australia
T:  +61 2 9213 4016
E: Thomas.howden@mci-group.com

Iridex

Iridex

At Iridex, we are redefining the glaucoma treatment paradigm with a versatile range of non-incisional, laser-based therapies: MicroPulse Laser Trabeculoplasty, MicroPulse Transscleral Laser Therapy, and Continuous-Wave Transscleral Cyclophotocoagulation. These therapies
provide physicians safe, effective, and versatile treatment options for a wide variety of glaucoma types and severities, to significantly reduce intraocular pressure and slow the progression of vision loss. More than 200,000 patients have been treated since 2015 with MicroPulse® TLT using the MicroPulse P3® Delivery Device. Visit iridex.com/webinars to learn how ophthalmologists and patients benefit from our non-incisional glaucoma procedures.

Kalson

Kalson Surgical

Bayer

Bayer Co. (Malaysia) Sdn Bhd

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. For more information, go to www.bayer.com.

DKSH_500x500

DKSH

DKSH is the leading growth partner for pharmaceutical companies in Asia. Our experts provide a range of integrated Market Expansion Services across the entire value chain, ranging from registration through to marketing, promotion and distribution.
Our capillary network reaches more than 130,000 hospitals, clinics, pharmacies, doctors and drugstores in Asia. Products are transported, stored and distributed efficiently thanks to our unmatched capacities and expertise in the region. Our solid infrastructure and dedication to compliance and quality reduce business risks for our partners.
We are committed to delivering the results you need to be successful. That’s why we continuously invest in our sales and marketing organization, which is fully embedded in our operations. Our teams work with clear measurements, activity-driven KPIs and standardized brand planning processes across the region. They are supported by regional Sales and Marketing Excellence and Business Development teams, allowing us to duplicate success across markets.
Headquartered and publicly listed in Switzerland, our local experts provide services to pharmaceutical companies in 13 Asian markets.

Glaukos Aventisin 500x500

Glaukos Corporation / Aventisin

Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.

We were the first company to bring to market Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure that revolutionized the treatment and management of glaucoma. In 2012, we launched our first MIGS device—the iStent®—in the United States, followed by our next-generation iStent inject® device in September 2018 and iStent inject® W in September 2020.

In November 2019, Glaukos acquired Avedro, maker of the first and only FDA-approved cross-linking technology for progressive keratoconus. And we continue to seek to leverage our platform technologies to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies for
glaucoma, corneal health, and retinal diseases.

Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol “GKOS”. Our global headquarters is located in Aliso Viejo, California, and we have additional locations in 9 regions around the world.

TRB

TRB Chemedica Malaysia

A subsidiary company of TRB CHEMEDICA INTERNATIONAL SA (Switzerland) established for almost 34 years in Malaysia, specialising in the use of hyaluronic acid in ophthalmology, rheumatology and orthopaedic for the management of ocular dryness, osteoarthritis and tendinopathy.

Nova Eye

Nova Eye Medical

With a legacy that spans more than 30 years in ophthalmology, Nova Eye Medical designs, develops, manufactures and markets a portfolio of proprietary glaucoma treatment technologies. Underpinning each of these technologies is our commitment to advance clinical outcomes and improve patient quality of life.

icare

Icare

iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD).
Our devices cover automated fundus imaging systems, perimeters, and handheld rebound tonometers. iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.
We believe that ophthalmic care must be accessible, effortless, and reliable, and our aim is to establish the next level of eye care.

Alcon

Alcon

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.

Santen

Santen

As a specialized company dedicated to ophthalmology, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and devices. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan and its products now reach patients in over 60 countries. With scientific knowledge and organizational capabilities nurtured over a 130-year history, Santen provides products and services to contribute to the well-being of patients, their loved ones and consequently to society. For more information, please visit https://www.santen.asia/

placeholder.png

Speaker Name

Sponsor bio – Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

placeholder.png

Sponsor Name

Sponsor bio – Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Contact